Medexus Pharmaceuticals Inc's total assets for Q3 2026 were C$154.98M, an increase of 3.71% from the previous quarter. TSE:MDP total liabilities were C$102.77M for the fiscal quarter, a 5.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.